Functional Technologies Reports Management Change

Functional Technologies Reports Management Change

ID: 132749

(firmenpresse) - VANCOUVER, BRITISH COLUMBIA -- (Marketwire) -- 04/05/12 -- Functional Technologies Corp. (TSX VENTURE: FEB) (the "Company") reported that Mr. Kito Tosetti has departed from the Company, effective immediately. The Board of Directors thanks Mr. Tosetti for his efforts, and wishes him well in his future endeavors.

About Functional Technologies Corp.

Functional Technologies develops and commercializes proprietary, advanced yeast-based solutions to significant challenges in the food, beverage and healthcare industries. The Company's platform improves the performance of innate yeast functions, and prevents the formation of naturally occurring toxins and contaminants that either affect final product quality or are classified by the World Health Organization as probable human carcinogens. Functional Technologies' lead technologies include yeasts that prevent and reduce the formation of the foul-smelling hydrogen sulphide (H2S) and the carcinogens acrylamide and ethyl carbamate (more commonly known as urethane), by-products of food and beverage processing. These contaminants are found in many commonly consumed items, such as fermented food products and alcoholic beverages, and baked and fried foods. With a head office in Vancouver, Functional Technologies Corp. has R&D operations in Prince Edward Island and Europe, as well as a U.S. sales office in Napa Valley, California. For more information, please visit our website at .

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION SERVICES PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.



Contacts:
Functional Technologies Corp.
Connie Chen, PhD
VP, Corporate Development and Communications
+1.647.282.5038



Weitere Infos zu dieser Pressemeldung:

Themen in dieser Pressemitteilung:


Unternehmensinformation / Kurzprofil:
drucken  als PDF  an Freund senden  Warnex Reports Year End 2011 Results Data Published in Premier Endocrinology Journal Shows Korlym(TM) Provides Significant Clinical Improvement in Patients With Endogenous Cushing's Syndrome
Bereitgestellt von Benutzer: MARKETWIRE
Datum: 05.04.2012 - 21:07 Uhr
Sprache: Deutsch
News-ID 132749
Anzahl Zeichen: 0

contact information:
Town:

VANCOUVER, BRITISH COLUMBIA



Kategorie:

Biotech



Diese Pressemitteilung wurde bisher 298 mal aufgerufen.


Die Pressemitteilung mit dem Titel:
"Functional Technologies Reports Management Change"
steht unter der journalistisch-redaktionellen Verantwortung von

Functional Technologies Corp. (Nachricht senden)

Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).


Alle Meldungen von Functional Technologies Corp.



 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
News zu Snacks finden Sie auf Snackeo.
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z